Cortical Sst Detector Cells plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:4023031 | L4 sst Martinotti interneuron (Mmus) |
Cortical somatostatin-expressing (SST+) interneurons are dendritic-targeting inhibitory neurons that play crucial roles in cortical circuit function. These cells function as "detectors" of local excitatory activity, providing sophisticated feedback inhibition that regulates synaptic plasticity, sensory processing, and cortical dynamics. SST detector cells represent approximately 20-30% of all cortical interneurons and are essential for proper cortical information processing. [1]
Unlike parvalbumin (PV) interneurons that provide perisomatic inhibition, SST neurons primarily target dendritic compartments of pyramidal neurons. This strategic positioning allows them to regulate the strength and plasticity of specific synaptic inputs before they are integrated at the soma. SST detector cells are thus critical for controlling which excitatory inputs are allowed to drive neuronal firing. [2]
SST detector cells are identified by characteristic molecular markers: [3]
SST detector cells exhibit distinctive morphologies optimized for dendritic targeting: [4]
The most characteristic SST interneurons are Martinotti cells: [5]
SST detector cells possess unique electrophysiological properties: [6]
SST detector cells provide powerful feedback inhibition: [7]
SST neurons regulate cortical gain:
In sensory cortices, SST neurons:
SST interneurons critically regulate synaptic plasticity:
SST neurons can create disinhibition:
SST detector cells show significant vulnerability in Alzheimer's disease:
Early Pathology
Mechanisms
Circuit Dysfunction
Therapeutic Implications
SST interneuron loss can be assessed:
Multiple approaches target SST neurons:
Key experimental approaches:
Optogenetics: SST-Cre driver lines
In vivo imaging: Calcium dynamics
Slice electrophysiology: Synaptic properties
Single-cell sequencing: Molecular profiling
Electron microscopy: Connectivity analysis
Cortex — Brain region containing SST detector cells
Somatostatin (SST) Protein — The defining neuropeptide
Pyramidal Neurons — Primary targets of SST inhibition
Alzheimer's Disease Disease with SST vulnerability
Neuropeptide Y — Cotransmitter
Interneurons — General interneuron types
Cortical Sst Detector Cells plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Cortical Sst Detector Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Xu H, et al. Diminished neuronal activity in neuronal survival in an Alzheimer's disease model. Nat Rev Neurosci. 2010;11(12):755-758. 2010. ↩︎
Rózsa B, et al. Somatostatin release from the somatodendritic compartment in dendritic spines. J Neurosci. 2017;37(3):604-614. 2017. ↩︎
Taniguchi H, et al. A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex. Neuron. 2011;71(6):995-1013. 2011. ↩︎
Fanselow EE, et al. Dendrodendritic inhibition in the olfactory bulb is driven by NMDA receptors. Proc Natl Acad Sci U S A. 2008;105(35):13193-13198. 2008. ↩︎
Silberberg G, Markram H. Disinhibition in neocortical microcircuits. Trends Neurosci. 2007;30(8):382-388. 2007. ↩︎
Kaplan ES, et al. Contrasting roles of parvalbumin-expressing interneurons in cortical oscillations. Proc Natl Acad Sci U S A. 2018;115(17):4404-4413. 2018. ↩︎
Morrison JH, et al. Somatostatin and mood: A potential target for treatment of depression and anxiety. J Neurosci. 2016;36(46):11082-11086. 2016. ↩︎